Multiple Myeloma Study Guide; Concise Information That Every Med Student, Physician, NP, and PA Should Know
Book Details
Author(s)JT Thomas MD
PublisherChart-MD
ISBN / ASINB00C4V3Z1E
ISBN-13978B00C4V3Z18
Sales Rank487,985
MarketplaceUnited States 🇺🇸
Description
Just the facts are included in this book. Written by a board certified medical oncologist, this is the perfect text if you are looking for a quick review of the information you need to know about multiple myeloma. We won’t waste your time with this rapid access information. The Multiple myeloma Study Guide has distilled the key details down to the concise facts that you will understand and remember.
The Multiple Myeloma Study Guide is an ideal resource for medical students and anyone who wants to understand more about Multiple myeloma.
Sample Text:
Fact: In the United States, the lifetime risk of getting multiple myeloma is 1 in 161 (0.62%).
Fact: Urinary monoclonal protein elevations in multiple myeloma are more likely to be kappa then lambda.
Fact: The del(17p) in multiple myeloma is associated with poor prognosis.
Fact: Subcutaneous dosing of bortezomib has a decreased incidence of peripheral neuropathy compared with IV administration.
The Multiple Myeloma Study Guide is an ideal resource for medical students and anyone who wants to understand more about Multiple myeloma.
Sample Text:
Fact: In the United States, the lifetime risk of getting multiple myeloma is 1 in 161 (0.62%).
Fact: Urinary monoclonal protein elevations in multiple myeloma are more likely to be kappa then lambda.
Fact: The del(17p) in multiple myeloma is associated with poor prognosis.
Fact: Subcutaneous dosing of bortezomib has a decreased incidence of peripheral neuropathy compared with IV administration.

